Runx3 deficiency results in myeloproliferative disorder in aged mice

Blood

Volumn 122, Issue 4, 2013, Pages 562-566

  Wang, Chelsia Qiuxia ^a,b   Motoda, Lena ^a   Satake, Masanobu ^c   Ito, Yoshiaki ^a,b   Taniuchi, Ichiro ^d   Tergaonkar, Vinay ^a   Osato, Motomi ^a,b,c,e,f  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TOHOKU UNIVERSITY   (Japan)

^d Institute of Physical and Chemical Research   (Japan)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR RUNX3; RUNX3 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKOCYTOSIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; STEM CELL MOBILIZATION; YOUNG ADULT; AGING; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CELL MOTION; DRUG EFFECT; GENE TRANSFER; GENETICS; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 3 SUBUNIT; GENE TRANSFER TECHNIQUES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOPROLIFERATIVE DISORDERS;

EID: 84886941879     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-10-460618     Document Type: Article

References (24)

1. Ito Y. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res. 2008;99:33-76.
2. Ito Y. Oncogenic potential of the RUNX gene family: ‘overview’. Oncogene. 2004;23(24): 4198-4208.
3. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002;2(7):502-513.
4. Osato M. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene. 2004;23(24):4284-4296.
5. Osato M, Asou N, Abdalla E, et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood. 1999;93(6): 1817-1824.
6. Motoda L, Osato M, Yamashita N, et al. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells. 2007;25(12): 2976-2986.
7. Jacob B, Osato M, Yamashita N, et al. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood. 2010;115(8):1610-1620.
8. Jacob B, Osato M. Stem cell exhaustion and leukemogenesis. J Cell Biochem. 2009;107(3): 393-399.
9. Motoda L, Osato M, Ito Y. Runx1/AML1 is a guardian of hematopoietic stem cells. Curr Cancer Therap Rev. 2008;4(3):188-195.
10. Wang CQ, Jacob B, Nah GS, Osato M. Runx family genes, niche, and stem cell quiescence. Blood Cells Mol Dis. 2010;44(4):275-286.
11. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005;106(2):494-504.
12. Ichikawa M, Asai T, Saito T, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med. 2004;10(3):299-304.
13. Putz G, Rosner A, Nuesslein I, Schmitz N, Buchholz F. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene. 2006; 25(6):929-939.
14. Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002;111(5):621-633.
15. Ng CE, Osato M, Tay BH, Venkatesh B, Ito Y. cDNA cloning of Runx family genes from the pufferfish (Fugu rubripes). Gene. 2007;399(2): 162-173.
16. Naoe Y, Setoguchi R, Akiyama K, et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J Exp Med. 2007;204(8):1749-1755.
17. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6(2):93-106.
18. Cottles GM, Osato M, Yokomizo T, et al. Hematological analysis of AML1/PEBP2 alpha B+/- mice: A possible predisposition to myeloid leukemia. Blood. 1999;94(10):218b.
19. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet. 1997;15(Spec No):417-474.
20. Mori N, Morosetti R, Lee S, et al. Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood. 1997;90(5):2010-2014.
21. Xie D, Hofmann WK, Mori N, Miller CW, Hoelzer D, Koeffler HP. Allelotype analysis of the myelodysplastic syndrome. Leukemia. 2000; 14(5):805-810.
22. Maddipoti SC, Bueso-Ramos C, Yang H, et al. Epigenetic silencing of the RUNX3 gene by promoter hypermethylation in patients with acute myeloid leukemia. Blood. 2008;112(11):3341.
23. Cheng CK, Li L, Cheng SH, et al. Transcriptional repression of the RUNX3/AML2 gene by the t(8; 21) and inv(16) fusion proteins in acute myeloid leukemia. Blood. 2008;112(8):3391-3402.
24. Gutiérrez NC, López-Pérez R, Hernández JM, et al. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia. 2005;19(3):402-409.